Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor platform update and does not affect study content or presented results.
    Difference
    0.1%
    Check dated 2026-07-06T16:37:53.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects an update to the page's version tag rather than changes to study content or functionality.
    Difference
    0.1%
    Check dated 2026-06-29T08:44:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants', indicating that enrollment is closed for this study. Other updates include adding navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updating the revision label to v3.6.0, along with minor formatting tweaks to headers.
    Difference
    0.5%
    Check dated 2026-06-15T08:28:44.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor site release. There are no changes to the study details or user-facing content evident in this update.
    Difference
    0.1%
    Check dated 2026-06-08T04:53:34.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A platform revision was updated from v3.5.3 to v3.5.4, indicating an underlying update to the site. It does not modify the study information or how the page is used.
    Difference
    0.1%
    Check dated 2026-05-17T10:21:53.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator changes from **Revision: v3.5.0** to **Revision: v3.5.3**, reflecting an update to the ClinicalTrials.gov site build rather than any study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.